Pyrrolo[2,3-g]-1,5-benzodiazepine,3,10-dihydro-2,4,8,9-tetramethyl- (113597-51-6)

Identification
Name:	Pyrrolo[2,3-g]-1,5-benzodiazepine,3,10-dihydro-2,4,8,9-tetramethyl-
Synonyms:	BRN 5541924;2,4,8,9-Tetramethyl-3H-(1,4)diazepino(2,3-g)indole;3,10-Dihydro-2,4,8,9-tetramethylpyrrolo(2,3-g)-1,5-benzodiazepine;Pyrrolo(2,3-g)-1,5-benzodiazepine, 3,10-dihydro-2,4,8,9-tetramethyl-;AC1MJ7PJ;LS-139192;113597-51-6
CAS:	113597-51-6
Molecular Formula:	C15H17 N3
Molecular Weight:	239.3156
InChI:	InChI=1/C15H17N3/c1-8-7-9(2)17-15-13(16-8)6-5-12-10(3)11(4)18-14(12)15/h5-6,18H,7H2,1-4H3
Molecular Structure:
Properties
Flash Point:	212°C
Boiling Point:	426.9°Cat760mmHg
Density:	1.2g/cm³
Refractive index:	1.647
Flash Point:	212°C
Safety Data

Other Product

3-(5,11a-Dihydro-9-hydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)-N-methylpropenamide
Pyrrolo[2'',3'':4',5']azepino[1',2':1,5]pyrrolo[3,2-f]indolizine-9-propanoicacid,2-[[4-(2-carboxyethyl)-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene]methyl]-4,5,10,12-tetrahydro-3,8,12,13-tetramethyl-10-oxo-,(Z)- (9CI)
10-[2-Chloro-4-(3-methyl-1H-pyrazol-1-yl)benzoyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine
6H-Pyrrolo[3,4-g]quinoline-5-carboxamide,7-[(4-fluorophenyl)methyl]-N-[(3-fluoro-2-pyridinyl)methyl]-7,8-dihydro-9-hydroxy-8-oxo-
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-11-sulfinicacid,2-(3-amino-3-oxo-1-propenyl)-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-,monosodium salt (9CI)
8H-Pyrrolo[3,4-g]quinolin-8-one,7-[(4-fluorophenyl)methyl]-6,7-dihydro-9-hydroxy-5-(2-phenylethenyl)-
Phosphonic acid,[[[3-[[7-[(4-fluorophenyl)methyl]-7,8-dihydro-9-hydroxy-5-methoxy-8-oxo-6H-pyrrolo[3,4-g]quinolin-6-yl]thio]-1-oxopropyl]amino]methyl]-, diethylester
6H-Pyrrolo[3,4-g]quinoline-5-carboxamide,7-[(4-fluorophenyl)methyl]-7,8-dihydro-9-hydroxy-8-oxo-N-[1-(3-pyridinyl)ethyl]-
Spiro[furan-2(5H),2'-[2H]furo[3,2-c]pyrrolo[1,2-a]azepin]-5-one,1'-ethyl-1',3'a,4',5',6',8',9',10',10'a,10'b-decahydro-4-methyl-8'-[(2R,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]-,(1'R,2S,3'aS,8'R,10'aR,10'bS)-rel-(-)-
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',- 4'(3'H)-dione,10'-(acetyloxy)-4'b,5',6',7',8',8'a,- 9',10'-octahydro-3',9'-dihydroxy-2,4'b,8',8'- tetramethyl-,(1S,2S,3'R,4'bS,8'aS,9'S,10'S)-
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',- 4'(3'H)-dione,3'-(acetyloxy)-4'b,5',6',7',8',8'a,- 9',10'-octahydro-9',10'-dihydroxy-2,4'b,8',8'- tetramethyl-,(1S,2R,3'R,4'bS,8'aS,9'S,10'S)-
Spiro[3H-indole-3,1'(5'H)-pyrrolo[1,2-b]- isoquinoline]-9'-carboxylic acid,1,2,2',3',5'a,6',7',8',9',9'a,10',10'adodecahydro- 8'-hydroxy-4-methoxy-2-oxo-,methyl ester,(1'R,5'aR,8'S,9'R,9'aS,10'aS)-
Spiro[cyclopropane-1,2'(3'H)-phenanthrene]-1',4'-dione,10'-(acetyloxy)-4'b,5',6',7',8',8'a,9',10'-octahydro-3',9'-dihydroxy-2,4'b,8',8'-tetramethyl-,(1S,2R,3'R,4'bS,8'aS,9'S,10'S)-
Spiro[furan-3(2H),7'(4'H)-naphtho[2,1-g]quinoline]-4',5,6',10'(4H,6'aH,7'aH)-tetrone,1',4'a,5',8',9',11',12'a,12'b-octahydro-2',5',7'a,12'a-tetramethyl-11'-[[(2R,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]methyl]-,(3S,4'aS,5'S,6'aR,7'aR,12'aS,12'bS)-rel-(+)- (9CI)
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H
1/C5H3BrN2O2/c6-5-4(8(9)10)2-1-3-7-5/h1-3
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
4H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine, 1-(5-bromo-3-pyridinyl)-8-chloro-5,6-dihydro-9-methoxy-4-methyl-
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',4',6'(3'H,5'H)-trione,9'-(acetyloxy)-4'b,8'a,9',10'-tetrahydro-3',10'-dihydroxy-2,4'b,7',8'-tetramethyl-,(1S,2S,3'R,4'bS,8'aS,9'S,10'S)- (9CI)
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',4'(3'H)-dione,10'-(acetyloxy)-4'b,5',6',8'a,9',10'-hexahydro-3',9'-dihydroxy-2,4'b,7',8'-tetramethyl-,(1S,2S,3'R,4'bS,8'aS,9'S,10'S)- (9CI)